FDA open to pooling data from ongoing Phase I/II studies of LX2006 with data from pivotal trial, and to earlier co-primary endpoint assessment, to support a Biologics License Application FDA approved ...
* FDA wants animal data showing drug batches work similarly * Lilly says same data may support lung, head & neck filings * Shares of Lilly down 4 percent By Ransdell Pierson NEW YORK, March 2 (Reuters ...
AstraZeneca (AZN) announced an update on their ongoing clinical study.Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback